U.S. Healthcare Passive Cold Chain Packaging Market To Reach $ 5.45 Billion By 2033

U.S. Healthcare Passive Cold Chain Packaging Market Growth & Trends

The U.S. healthcare passive cold chain packaging market size is anticipated to reach USD 5.45 billion by 2033, expanding at a CAGR of 11.9% from 2026 to 2033, according to a new report by Grand View Research, Inc. The market is primarily driven by the growing volume of temperature-sensitive pharmaceutical products, including biologics, vaccines, cell and gene therapies, and other specialty medicines. These products require strict temperature control throughout storage and transportation to preserve efficacy and avoid degradation. As the U.S. pharmaceutical pipeline continues shifting toward high-value biologic and personalized treatments, the need for reliable passive packaging systems that ensure thermal stability during distribution is expanding rapidly.

An increasing regulatory focus on product safety and distribution quality is also contributing to the growth of the market. U.S. healthcare supply chains operate under stringent requirements from agencies such as the FDA, which emphasize Good Distribution Practices, packaging validation, and documented compliance. Pharmaceutical manufacturers and logistics providers are therefore investing in high-performance passive cold chain solutions that offer proven thermal protection, standardized qualification, and traceability to reduce the risk of temperature excursions and regulatory non-compliance.

The expansion of last-mile healthcare logistics is further accelerating market growth. Direct-to-patient delivery models, decentralized clinical trials, and wider distribution of specialty drugs to pharmacies, hospitals, and outpatient centers require efficient and scalable cold chain packaging. Passive systems are widely adopted in these applications due to their operational simplicity, cost-effectiveness compared to active systems, and ability to support short and medium-duration shipments across domestic supply networks.

Moreover, continuous innovation in packaging materials and thermal technologies is strengthening demand, particularly as sustainability becomes a strategic priority. Advances in phase change materials, vacuum insulated panels, and engineered insulation systems are improving temperature hold performance and reliability under varying transit conditions. For instance, in September 2025, TemperPack launched its Qualified Shipper Program, offering more than 60 ISTA-tested thermal shippers integrated with compostable GreenCell Foam, optimized coolants, and compliant packaging formats to support sustainable, cost-efficient shipping of temperature-sensitive medications. Such developments highlight how innovation and environmentally responsible solutions are increasingly shaping adoption across the U.S. healthcare cold chain ecosystem.

 Request a free sample copy or view report summary: U.S. Healthcare Passive Cold Chain Packaging Market Report

U.S. Healthcare Passive Cold Chain Packaging Market Report Highlights

• Based on products, the insulated containers segment led the market in 2025, accounting for more than 39.0% of total revenue.

• The insulated pallet shippers segment is anticipated to register the fastest growth, expanding at a CAGR of 12.7% over the forecast period.

• Based on temperature requirement, the refrigerated and chilled (2°C to 8°C) segment dominated the market in 2025, representing over 46.0% of overall revenue share.

• The frozen (−20°C to ±5°C) segment is expected to grow at the highest CAGR of 12.6% during the forecast period.

• Based on end use, pharmaceutical and biopharmaceutical companies emerged as the largest segment in 2025, capturing more than 40.0% of the market share.

U.S. Healthcare Passive Cold Chain Packaging Market Segmentation

Grand View Research has segmented the U.S. healthcare passive cold chain packaging market based on product, temperature requirement, end use, and region:

U.S. Healthcare Passive Cold Chain Packaging Product Outlook (Revenue, USD Million, 2021 - 2033)

• Insulated Containers

• Insulated Pallet Shippers 

• Gel Packs, Dry Ice Systems, PCM

• Others

U.S. Healthcare Passive Cold Chain Packaging Temperature Requirement Outlook (Revenue, USD Million, 2021 - 2033)

• Refrigerated / Chilled (2°C to 8°C)

• Frozen (−20 °C to ±5 °C)

• Cool / Controlled Chilled (8 °C to 15 °C)

• Controlled Room Temperature (CRT)

• Deep Frozen (−40 °C to −60 °C)

U.S. Healthcare Passive Cold Chain Packaging End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Pharmaceutical & Biopharmaceutical Companies

• Hospitals & Healthcare Providersa

• Diagnostic & Pathology Laboratories

• Research Institutes & Academic Laboratories

• Clinical Research Organizations (CROs)

• Blood Banks & Plasma Collection Centers

• Others

List of Key Players in the U.S. Healthcare Passive Cold Chain Packaging Market

• ThermoSafe

• Cold Chain Technologies

• Peli BioThermal LLC

• Cryopak 

• CSafe 

• Intelsius

• TemperPack

• Coldkeepers, LLC

• Polar Tech Industries

• Creative Packaging Co.